Source: Pharmabiz

Morepen: Morepen Labs posts 10% fall in Q3 net profit at Rs. 21.52 crore

Morepen Laboratories Limited, a leading player in pharma market, has posted 10 per cent decline in consolidated net profit to Rs. 21.52 crore despite a 29 per cent increase in net income from operations to Rs. 396.49

Read full article »
Annual Revenue
$100-500M
Employees
1.0-5.0K
Sushil Suri's photo - Managing Director of Morepen

Managing Director

Sushil Suri

CEO Approval Rating

- -/100